Laura Evgin
@EvginLab
Followers
229
Following
160
Media
0
Statuses
22
Scientist at Canada's Michael Smith Genome Sciences Centre at BC Cancer Assistant Professor, Department of Medical Genetics, University of British Columbia
Vancouver, BC
Joined November 2020
We have a new lab website! Check out what our team is doing in the lab.
evginlab.com
The Evgin lab is working to make CAR T cell therapies for cancer and autoimmune diseases more effective and accessible.
0
0
4
We are looking for a postdoctoral fellow to join our lab at @BCCancer_GSC. Apply here: Read more about our work on our new lab website!
evginlab.com
The Evgin lab is working to make CAR T cell therapies for cancer and autoimmune diseases more effective and accessible.
0
7
4
We are very happy to share our review about engineering CAR T cells directly in vivo.
cell.com
T cells modified to express intelligently designed chimeric antigen receptors (CARs) are exceptionally powerful therapeutic agents for relapsed and refractory blood cancers and have the potential to...
1
10
34
My fantastic team made a podcast about immunotherapy. Check it out! Episode 2 features a great interview with @Smience about CAR T cell therapy in Canada.
podcasts.apple.com
Life Sciences Podcast · Updated Monthly · What the HEK is immunotherapy? With this podcast we are trying to answer that question! Through interviews with professors, students, patients, and other...
1
1
7
RT @ScienceVancity: 🎉 @tfri_research has announced the Canadian @cancersociety’s inaugural Research Training Awards. We extend a hearty co….
0
2
0
RT @SciImmunology: Prior gammaherpesvirus infection can limit allergic airway inflammation by reprogramming lung group 2 innate lymphoid ce….
0
7
0
I am looking for a research associate. Come join our team @BCCancer_GSC in beautiful Vancouver to work on CAR T cell therapy! See more here:
0
12
16
RT @aalkayyal1: @EvginLab, @Tai_ImmunoLab, @Ahmad_B_Mahmoud and I have been invited to guest edit a special issue on “Strategies in Oncolyt….
frontiersin.org
Oncolytic virotherapy (OV) is a novel modality that selectively replicates in and kills cancer cells, while sparing normal cells. It has gained momentum due to its profound efficacy in clinical...
0
4
0
Happy to share our new paper out yesterday in @ScienceTM from my post doc lab @RVilePhD! The native TCR in CAR T cells is important and can be leveraged with OV-derived antigens.
science.org
Viral antigens and virally encoded antigens expand CAR T cells and endow them with potent antitumor phenotypic and functional properties.
5
9
22
RT @BCCancer_GSC: Interested in original #science, helping #CancerPatients, furthering #CancerResearch, #LifeScience, realizing #PrecisionM….
0
17
0
I’m looking for a post doc to work on a project using viruses and vaccines to improve CAR T efficacy in lymphoma. Come work for me @BCCancer_GSC in beautiful Vancouver!
2
17
22
Looking forward to it @Tai_ImmunoLab!.
Beautiful drawing of Lauralie Short, MSc student in my lab @cellimmunoUdeS @USherbrooke. I'm thrilled that she will start her PhD studies with @EvginLab this fall where she will combine her oncolytic virus expertise with CAR-T cells.
0
0
3
Very happy to share our new review about combining CAR T and OVs! @RVilePhD @BCCancer_GSC
mdpi.com
Oncolytic viruses (OVs) and adoptive T cell therapy (ACT) each possess direct tumour cytolytic capabilities, and their combination potentially seems like a match made in heaven to complement the...
0
3
7
RT @LindoSci: Delighted to announce that my first ever review has been published in @FrontImmunol! We review how the TME can restrict CAR….
frontiersin.org
T-cells genetically engineered to express a chimeric antigen receptor (CAR) have shown remarkable results in patients with B-cell malignancies, including B-c...
0
2
0
RT @BioCanRx: Register now for our upcoming #Summit4CISpeakerSeries, featuring Dr. Carolina Ilkow @CIlkow of the @OttawaHospital & @uOttawa….
0
3
0
Excited about cancer immunotherapy? I'm looking for a staff scientist to work with me @BCCancer @BCCancer_GSC #CART.More info:
1
13
15
I'm very proud to start at Canada's Michael Smith Genome Sciences Centre @BCCancer and UBC Department of Medical Genetics @UBCmedicine . Read about my research here.
3
3
22